Suchergebnisse - "Wolanskyj, Alexandra"

PubPharm (97)

1

Bortezomib and daratumumab in refractory autoimmune hemolytic anemia

enthalten in: American journal of hematology | 2023

von McGlothlin, J. | Abeykoon, J. | Al-Hattab, E. | +9

2

De novo isolated myeloid sarcoma : comparative analysis of survival in 19 consecutive cases

enthalten in: British journal of haematology | 2021

von Begna, K. | Kittur, J. | Yui, J. | +13

3

Acute myeloid leukemia after age 70 years : A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy

enthalten in: American journal of hematology | 2021

von Begna, K. | Gangat, N. | Al-Kali, A. | +10

4

Acute myeloid leukemia after age 70 years : A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy

enthalten in: American Journal of Hematology | 2021

von Begna, K. | Gangat, N. | Al‐Kali, A. | +10

5

De novo isolated myeloid sarcoma : comparative analysis of survival in 19 consecutive cases

enthalten in: British Journal of Haematology | 2021

von Begna, K. | Kittur, J. | Yui, J. | +13

6

Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN overlap neoplasms

enthalten in: Leukemia | 2020

von DiFilippo, E. | Coltro, G. | Carr, R. | +15

7

Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

enthalten in: American journal of hematology | 2020

von Anagnostou, T. | Knudson, R. | Pearce, K. | +25

8

Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like ( P hiladelphia chromosome like) B‐acute lymphoblastic leukemia

enthalten in: American Journal of Hematology | 2020

von Anagnostou, T. | Knudson, R. | Pearce, K. | +25

9

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms : Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

enthalten in: Mayo Clinic proceedings | 2019

von Szuber, N. | Mudireddy, M. | Nicolosi, M. | +16

10

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

enthalten in: American journal of hematology | 2019

von Tefferi, A. | Szuber, N. | Vallapureddy, R. | +9

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]